Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene.
Most papers first2,901 to 2,920 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| GLS2 glutaminase 2 | 27165 HGNC:29570 | 1 | 22 | 0 | 0 | 1,287 | 2,122 |
| TDG thymine DNA glycosylase | 6996 HGNC:11700 | 1 | 45 | 0 | 0 | 1,461 | 2,121 |
| TIAM1 TIAM Rac1 associated GEF 1 | 7074 HGNC:11805 | 1 | 21 | 0 | 0 | 1,538 | 2,121 |
| NTSR1 neurotensin receptor 1 | 4923 HGNC:8039 | 1 | 49 | 1 | 1 | 1,420 | 2,119 |
| CCNT1 cyclin T1 | 904 HGNC:1599 | 1 | 36 | 0 | 0 | 1,696 | 2,118 |
| IGKV2D-24 immunoglobulin kappa variable 2D-24 (non-functional) | 28885 HGNC:5797 | 1 | 4 | 0 | 0 | 1,367 | 2,118 |
| TPH1 tryptophan hydroxylase 1 | 7166 HGNC:12008 | 1 | 27 | 4 | 15 | 1,370 | 2,118 |
| UGCG UDP-glucose ceramide glucosyltransferase | 7357 HGNC:12524 | 1 | 52 | 5 | 54 | 1,076 | 2,116 |
| SEC61A1 SEC61 translocon subunit alpha 1 | 29927 HGNC:18276 | 1 | 50 | 0 | 0 | 1,700 | 2,113 |
| CYP51A1 cytochrome P450 family 51 subfamily A member 1 | 1595 HGNC:2649 | 1 | 37 | 0 | 0 | 1,049 | 2,112 |
| LPAR1 lysophosphatidic acid receptor 1 | 1902 HGNC:3166 | 1 | 158 | 1 | 2 | 1,431 | 2,112 |
| TRPM2 transient receptor potential cation channel subfamily M member 2 | 7226 HGNC:12339 | 1 | 32 | 0 | 0 | 859 | 2,111 |
| H4C4 H4 clustered histone 4 | 8360 HGNC:4782 | 1 | 408 | 0 | 0 | 432 | 2,107 |
| IKZF3 IKAROS family zinc finger 3 | 22806 HGNC:13178 | 1 | 64 | 0 | 0 | 1,840 | 2,106 |
| PLK4 polo like kinase 4 | 10733 HGNC:11397 | 1 | 20 | 3 | 5 | 1,134 | 2,106 |
| SRSF3 serine and arginine rich splicing factor 3 | 6428 HGNC:10785 | 1 | 43 | 0 | 0 | 1,293 | 2,106 |
| BRD3 bromodomain containing 3 | 8019 HGNC:1104 | 1 | 61 | 6 | 42 | 1,701 | 2,104 |
| RCOR1 REST corepressor 1 | 23186 HGNC:17441 | 1 | 46 | 0 | 0 | 1,838 | 2,104 |
| FGF3 fibroblast growth factor 3 | 2248 HGNC:3681 | 1 | 122 | 0 | 0 | 1,053 | 2,103 |
| MIR217 microRNA 217 | 406999 HGNC:31594 | 0 | 0 | 0 | 0 | 525 | 2,102 |
Code
curl "https://conductscience.org/api/genes/v1?page=146"
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=146
{
"data": {
"total": 193990,
"results": [
{
"id": "27165",
"title": "GLS2: glutaminase 2",
"summary": "NCBI Gene 27165. 1 protein, 22 patents, 0 drugs, 0 trials, 1,287 NIH grants and 2,122 papers.",
"record": "/library/genes/27165",
"gene_id": 27165,
"symbol": "GLS2",
"name": "glutaminase 2",
"hgnc_id": "HGNC:29570",
"counts": {
"proteins": 1,
"patents": 22,
"drugs": 0,
"trials": 0,
"grants": 1287,
"papers": 2122
}
},
{
"id": "6996",
"title": "TDG: thymine DNA glycosylase",
"summary": "NCBI Gene 6996. 1 protein, 45 patents, 0 drugs, 0 trials, 1,461 NIH grants and 2,121 papers.",
"record": "/library/genes/6996",
"gene_id": 6996,
"symbol": "TDG",
"name": "thymine DNA glycosylase",
"hgnc_id": "HGNC:11700",
"counts": {
"proteins": 1,
"patents": 45,
"drugs": 0,
"trials": 0,
"grants": 1461,
"papers": 2121
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.2.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "Public domain (US government)"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=147",
"request_id": "thlqYfq1RlONyei4"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant